Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|April 26, 2025
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trialAziz Zaanan, Olivier Bouché, Christelle de la Fouchardière, et al.
Signal Transduction and Targeted Therapy|April 14, 2026
STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancerBenoist Chibaudel, Louis-Marie Dourthe, Thierry André, et al.
Communications Medicine|April 24, 2025
Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinomaDavid Tougeron, Christophe Louvet, Jérôme Desramé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2025
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France TrialsClaire Gallois, Marine Sroussi, Thierry André, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD studyBenoit Rousseau, Marc Hilmi, Antoine Falcoz, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2021
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)David Tougeron, Maxime Hentzien, Barbara Seitz-Polski, et al.
The Lancet. Oncology|April 16, 2021
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trialThierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2015
Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinomaRaphaël Maréchal, Jean-Baptiste Bachet, Annabelle Calomme, et al.
Gynecologic Oncology|December 13, 2024
Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trialHenri Azaïs, Camille Brochard, Valérie Taly, et al.
Bulletin Du Cancer|April 27, 2021
[Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]David Tougeron, Barbara Seitz-Polski, Maxime Hentzien, et al.
Pageof 14